Saturday, September 23, 2023
Saturday, September 23, 2023

Cryoanalgesia and Non-Opioid Options Are Changing the Way We Manage Pain. Expert Shares His Views

By: Anthony Cuneo, MD, PhD

Cryoanalgesia and Non-Opioid Options: Physical Medicine and Rehabilitation specialist at Monongahela Valley Hospital in Pittsburgh, PA.

As a specialist in Physical Medicine and Rehabilitation, I strive to help patients improve their function and pain. Therefore, it is paramount that I’m consistently well-informed of the latest clinical research and innovations within my field.

While certain medications, like opioids, have been widely used for pain management, heightened awareness around their associated risks and the current addiction epidemic has driven me, and my fellow physicians, to seek out safe and effective alternatives. I am especially encouraged by the growing arsenal of pain management options available, including non-opioid medications and non-pharmacologic interventions, that successfully stave off pain and reduce unnecessary exposure to opioids. In fact, I’ve adopted a number of non-opioid approaches into my practice that enhance the overall experience of my patients.

Through my work, I frequently see patients dealing with chronic osteoarthritis (OA) pain who are not yet candidates for a total knee arthroplasty (TKA) surgery or want to put off surgery for one reason or another. In both of these instances, I’ve found great success utilizing cryoanalgesia. Cryoanalgesia is a type of cryotherapy that applies intensely focused and controlled cold therapy to a specific nerve to prevent its ability to transmit a pain signal to the brain.

Essentially it harnesses the body’s own natural response to cold to help reduce pain. In my practice, I utilize cryoanalgesia with iovera°, a non-opioid treatment system that delivers highly focused doses of cold temperature with a portable handheld device to cease pain signal transmission. Until now, traditional cryotherapy treatments were invasive and used large, complicated machines.

With the iovera° handheld device, I am able to deliver precise, controlled doses of cold temperature only to the targeted nerve. The administration of the therapy is easy and quick, typically only requiring a 15-minute treatment, which often provides my patients with immediate opioid-free pain relief for up to 90 days. Importantly, the treated nerves are only temporarily blocked from sending pain signals, meaning the body fully restores nerve function after the nerves regenerate.

For many patients, the use of cryoanalgesia has been a gamechanger, especially when administered several days before a planned TKA surgery. Through this approach, I’m able to decrease pain medication use and discomfort prior to and following surgery.  Many times, my patients are walking better almost immediately following the treatment. Further, with their knee pain under control, many patients can now face surgery and rehab with a higher degree of comfort and confidence.

Most importantly, it has helped significantly reduce the need for opioids to control pain both before and after surgery; therefore, we’re able to reduce the potential for unwanted opioid-related side effects such as nausea, vomiting, constipation, and the risk of addiction or dependence. In fact, a study found that TKA patients who received cryoanalgesia therapy via iovera° required 45% less opioids during the 12 weeks following surgery.

As clinicians, it’s important we make every effort to be at the forefront of turning the tide of this epidemic through effective non-opioid approaches. In fact, my Orthopedic surgical colleagues, who perform the TKA procedures that I prep patients for, use a non-opioid option for TKA, called EXPAREL® (bupivacaine liposome injectable suspension).

EXPAREL is a long-acting local anesthetic that is injected into the surgical site during surgery. Due to the long-lasting, numbing nature of this product, it can provide relief in the first few days following surgery when pain is often at its peak. Through our adoption of non-opioid options like EXPAREL and iovera°, our practice has seen a 36% reduction in post-discharge opioid use, and often, our patients’ pain is very well managed.

With the world around us constantly evolving, pain management strategies must adapt and evolve as well. I am passionate about, and committed to, educating my peers and patients about my experience and success with non-opioid options to manage pain. As our nation continues to combat the opioid epidemic, it is imperative that we as clinicians make every effort to stay up to date on alternatives that reduce our reliance on opioids, while providing our patients with the effective pain relief they rely on us for.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Experts Views and Opinions

The Hollywood Writers’ Strike and Ethical AI | By Ed Watal, Founder & Principal — Intellibus

Watal writes, "Less than 12 months ago, with the debut of AI-powered ChatGPT, the true power of AI hit the mainstream. Since then, it has established an unshakeable belief in everyone’s minds that artificial intelligence is here to stay and will forever alter a number of industries." What do you think? Read on.

Viraj Gandhi On Automation and Technology – to Drive Progress in Pharmaceutical Manufacturing

This article takes a closer look at the key benefits of automation and technology in pharmaceutical manufacturing and how Medivant Healthcare harnesses these solutions to drive progress across our production facilities. Read what Viraj Gandhi has to say.

Limb Loss and Preservation Registry (LLPR) Transforms Care Through Data and Insights | By Shawn Murphy, Vice President, Thought Leadership & Innovation Foundation...

Shawn Murphy writes, "The Limb Loss and Preservation Registry (LLPR) represents a pivotal development in patient care. It stands as the first collaborative database that unites hospital and health systems, provider organizations such as Accountable Care Organizations (ACOs), Integrated Delivery Networks (IDNs) and orthotic/prosthetic (O&P) practices, focusing on both upper and lower extremity acquired and congenital limb differences, as well as limb preservation populations. This collective effort has the potential to drive substantial advancements in patient outcomes, treatment effectiveness and care quality." Read to learn more.

It Takes an Ecosystem – Bringing Stakeholders Together is a Critical 1st Step to Solving Problems In Healthcare | By Andrew Cleeland, CEO, Fogarty...

Andrew Cleeland writes, "Introducing a new medical therapy or technology is a complex, expensive, and time-consuming journey, one that is fraught with significant risk. While innovation often starts with a clear, well-defined unmet clinical need, it must be paired with an equally compelling value proposition. My mentor, Dr. Thomas Fogarty, once said, “An idea, by itself, has no importance whatsoever; it is the implementation of that idea and its acceptance by others that brings benefit to our patients.” Read on.

Chemotherapy Starts With Scalp Cooling Treatment: The Path to Improved Access | By Claire Paxman, Director of Global Training of Paxman

Paxman writes, "When Real Housewives of Miami star Guerdy Abraira recently proclaimed “Chemo Starts Now” after shaving off her hair before starting her treatment for breast cancer in People Magazine1, this made me realize just how little the general public and even celebrities like Abraria know about the medical technology being utilized today, such as scalp cooling systems, to manage and prevent chemotherapy-induced hair loss." Read to learn more.

By using this website you agree to accept Medical Device News Magazine Privacy Policy